India to United States: Pantoprazole Export Trade Route
India has recorded 919 verified shipments of Pantoprazole exported to United States, representing a combined trade value of $876.6M USD. This corridor is served by 26 active Indian exporters, with an average shipment value of $953.9K USD. The leading Indian exporter is MYLAN LABORATORIES LIMITED, which accounts for 95% of total export value with 180 shipments worth $829.5M USD. On the buying side, MYLAN PHARMACEUTICALS INC, is the largest importer in United States with $816.1M USD in purchases. The top 3 suppliers — MYLAN LABORATORIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, TORRENT PHARMACEUTICALS LTD — together control 97% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Pantoprazole corridor is one of India's established pharmaceutical export routes, with 919 shipments documented worth a combined $876.6M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 95% of all export value, reflecting the consolidated nature of India's pantoprazole manufacturing sector.
Across 26 active suppliers, the average shipment value stands at $953.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with pantoprazole's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 17.0%, placing it at rank #14 among India's top pantoprazole export destinations globally.
On the import side, key buyers of Indian pantoprazole in United States include MYLAN PHARMACEUTICALS INC,, EUGIA US LLC, MYLAN PHARMACEUTICALS INC and 54 others. MYLAN PHARMACEUTICALS INC, is the single largest importer with 57 shipments valued at $816.1M USD.
Route Characteristics
- Average transit27 days
- Peak seasonQ1
- Primary modeSea freight
- Top portHYDERABAD ICD
Market Position
- Global rank#14
- Annual growth+17.0%
- Demand growth+16.5%
- Regulatory ease82/100
Top 10 Indian Pantoprazole Exporters to United States
Showing top 10 of 26 Indian suppliers exporting Pantoprazole to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED Avg $4.6M per shipment | 180 | $829.5M | 94.6% |
| 2 | EUGIA PHARMA SPECIALITIES LIMITED Avg $101.4K per shipment | 130 | $13.2M | 1.5% |
| 3 | TORRENT PHARMACEUTICALS LTD Avg $42.3K per shipment | 144 | $6.1M | 0.7% |
| 4 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED Avg $48.9K per shipment | 72 | $3.5M | 0.4% |
| 5 | TORRENT PHARMACEUTICALS LIMITED Avg $43.4K per shipment | 71 | $3.1M | 0.4% |
| 6 | AUROBINDO PHARMA LIMITED Avg $114.0K per shipment | 24 | $2.7M | 0.3% |
| 7 | GLAND PHARMA LTD Avg $48.9K per shipment | 55 | $2.7M | 0.3% |
| 8 | HETERO LABS LIMITED Avg $50.7K per shipment | 47 | $2.4M | 0.3% |
| 9 | AJANTA PHARMA LIMITED Avg $171.5K per shipment | 13 | $2.2M | 0.3% |
| 10 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $413.5K per shipment | 5 | $2.1M | 0.2% |
This table shows the top 10 of 26 Indian companies exporting pantoprazole to United States, ranked by total trade value. The listed exporters are: MYLAN LABORATORIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, TORRENT PHARMACEUTICALS LTD, AMNEAL PHARMACEUTICALS PRIVATE LIMITED, TORRENT PHARMACEUTICALS LIMITED, AUROBINDO PHARMA LIMITED, GLAND PHARMA LTD, HETERO LABS LIMITED, AJANTA PHARMA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED. MYLAN LABORATORIES LIMITED is the dominant supplier with 180 shipments worth $829.5M USD, giving it a 95% market share. The top 3 suppliers together account for 97% of the total trade value on this route.
Showing top 10 of 26 total Indian exporters on the India to United States Pantoprazole export route.
Top 10 Pantoprazole Importers in United States
Showing top 10 of 57 known buyers in United States receiving Pantoprazole shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian pantoprazole in United States include MYLAN PHARMACEUTICALS INC,, EUGIA US LLC, MYLAN PHARMACEUTICALS INC, TORRENT PHARMA INC, XXROBXXDO XXARMXXUSAXXNC, among 57 total buyers. The largest importer is MYLAN PHARMACEUTICALS INC,, accounting for $816.1M USD across 57 shipments — representing 93% of all pantoprazole imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MYLAN PHARMACEUTICALS INC, | 57 | $816.1M | 93.1% |
| 2 | EUGIA US LLC | 97 | $11.0M | 1.3% |
| 3 | MYLAN PHARMACEUTICALS INC | 98 | $9.1M | 1.0% |
| 4 | TORRENT PHARMA INC | 121 | $5.5M | 0.6% |
| 5 | XXROBXXDO XXARMXXUSAXXNC | 23 | $2.7M | 0.3% |
| 6 | TORRENT PHARMA INC, | 63 | $2.4M | 0.3% |
| 7 | MYLANPHARMACEUTICALS INC | 13 | $2.3M | 0.3% |
| 8 | EUGIA US LLC, | 33 | $2.2M | 0.2% |
| 9 | AMNEAL PHARMACEUTICALS, LLC (KY) | 40 | $2.0M | 0.2% |
| 10 | MYLAN PHARMACEUTICALS INC., | 12 | $1.9M | 0.2% |
Showing top 10 of 57 Pantoprazole importers in United States on this route.
Top 10 Pantoprazole Formulations Imported by United States
Showing top 10 of 418 product formulations shipped on the India to United States Pantoprazole route, ranked by trade value
United States imports a wide range of pantoprazole formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS USP 40 MG 1000BT 29280 PACKS — accounts for $404.6M USD across 1 shipments. There are 418 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS USP 40 MG 1000BT 29280 PACKS | 1 | $404.6M | 46.2% |
| 2 | PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS USP 40 MG 1000BT 9837 PACKS | 1 | $135.7M | 15.5% |
| 3 | PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS USP 40 MG 1000BT9811 PACKS | 1 | $135.3M | 15.4% |
| 4 | PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS USP 40 MG 1000BT 9797 PACKS | 1 | $135.1M | 15.4% |
| 5 | PANTOPRAZOLE SODIUM DELAYED-RELEASE TABL | 27 | $3.1M | 0.4% |
| 6 | PANTOPRAZOLE SODIUM FOR DELAYED RELEASE | 13 | $2.2M | 0.3% |
| 7 | PANTOPRAZOLE SODIUM FOR INJECTION 40 MG | 15 | $1.6M | 0.2% |
| 8 | PANTOPRAZOLE SODIUM FOR INJECTION 40 MG/ | 8 | $1.5M | 0.2% |
| 9 | PANTOPRAZOLE TABLETS 40 MG 1000'S PACK | 11 | $1.5M | 0.2% |
| 10 | PANTOPRAZOLE SODIUM FOR INJECTION 40MG/VIAL 10ML LYO VIAL | 14 | $1.3M | 0.2% |
Showing top 10 of 418 Pantoprazole formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 78%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD ICD handles the highest volume with 140 shipments. Transit time averages 27 days by sea.
Market Dynamics
India's pantoprazole exports to United States are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 180 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 26 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MYLAN LABORATORIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, TORRENT PHARMACEUTICALS LTD — together account for 97% of total trade value on this route. The average shipment value of $953.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as pantoprazole sodium delayed-release tablets usp 40 mg 1000bt 9837 packs and pantoprazole sodium delayed-release tablets usp 40 mg 1000bt9811 packs, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, MYLAN PHARMACEUTICALS INC, is the largest importer with 57 shipments worth $816.1M USD — representing 93% of all pantoprazole imports from India on this route. A total of 57 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $876.6M
- Avg. Shipment
- $953.9K
- Suppliers
- 26
- Buyers
- 57
- Transit (Sea)
- ~27 days
- Annual Growth
- +17.0%
Related Analysis
Reverse Direction
United States → India — Pantoprazole (Import)Other Pantoprazole Routes
Unlock the Full India to United States Pantoprazole Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 919 shipments on this route.
Frequently Asked Questions — India to United States Pantoprazole Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Pantoprazole to United States?
The leading Indian exporters of Pantoprazole to United States are MYLAN LABORATORIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, TORRENT PHARMACEUTICALS LTD. MYLAN LABORATORIES LIMITED holds the largest market share at approximately 95% of total trade value on this route.
Q What is the total value of Pantoprazole exports from India to United States?
India exports Pantoprazole to United States worth approximately $876.6M USD across 919 recorded shipments. The average value per shipment is $953.9K USD.
Q Which ports does India use to ship Pantoprazole to United States?
The most active port of origin is HYDERABAD ICD with 140 shipments. Indian exporters primarily use sea freight for this route, with 78% of shipments going by sea and 25% by air.
Q How long does shipping take from India to United States for Pantoprazole?
The average transit time for Pantoprazole shipments from India to United States is approximately 27 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Pantoprazole trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 17.0% with demand growth tracking at 16.5%. The route is ranked #14 among India's top Pantoprazole export destinations globally.
Q How many suppliers are active on the India to United States Pantoprazole route?
There are currently 26 active Indian suppliers exporting Pantoprazole to United States. The market is moderately concentrated with MYLAN LABORATORIES LIMITED accounting for 95% of total shipment value.
Q Who are the main importers of Pantoprazole from India in United States?
The leading importers of Indian Pantoprazole in United States include MYLAN PHARMACEUTICALS INC,, EUGIA US LLC, MYLAN PHARMACEUTICALS INC, TORRENT PHARMA INC, XXROBXXDO XXARMXXUSAXXNC. MYLAN PHARMACEUTICALS INC, is the largest buyer with 57 shipments worth $816.1M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Pantoprazole.
- 2.Supplier/Buyer Matching: 26 Indian exporters and 57 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 919 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
919 Verified Shipments
26 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists